Gastractiv
Gastractiv is a prescription combination medication containing Rabeprazole and Levosulpiride. Rabeprazole is a proton pump inhibitor (PPI) that decreases stomach acid production, while Levosulpiride is a prokinetic agent that enhances gastrointestinal motility. Together, they help prevent acid reflux, relieve heartburn, and improve gut transit.
Dosage by Body Weight
Strictly follow your doctor's instructions. Usually prescribed as one capsule daily in the morning on an empty stomach, at least 30 minutes before breakfast. Swallow the capsule whole; do not chew or crush it.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- Do not administer
- Tracking Notes
- Safety and efficacy have not been established for infants and children.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- Do not administer
- Tracking Notes
- Safety and efficacy have not been established for infants and children.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- Do not administer
- Tracking Notes
- Safety and efficacy have not been established for children.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- Do not administer
- Tracking Notes
- Safety and efficacy have not been established for children.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- Do not administer
- Tracking Notes
- Safety and efficacy have not been established for children.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | Do not administer | Safety and efficacy have not been established for infants and children. |
| 5-7 kg | Not recommended | Do not administer | Safety and efficacy have not been established for infants and children. |
| 8-10 kg | Not recommended | Do not administer | Safety and efficacy have not been established for children. |
| 11-15 kg | Not recommended | Do not administer | Safety and efficacy have not been established for children. |
| 16-20 kg | Not recommended | Do not administer | Safety and efficacy have not been established for children. |
Formulation
Purpose
Treatment of gastroesophageal reflux disease (GERD), acid reflux, peptic ulcers, dyspepsia (indigestion), and irritable bowel syndrome (IBS).
Generic Name
Rabeprazole + LevosulpirideScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.